Anticoagulant Rodenticides Market Share Expected to Grow Over USD 921.56 Million By 2030

Anticoagulant Rodenticides Market

The increased demand for mosquito control solutions to reduce the growing rodent population and efforts to stop illness caused by them are driving the market expansion. For instance, Rentokil PCI provides a call-out solution for rats and other pest control issues in the home.  Also, according to the CDC, rats, and mice are responsible for the transmission of over 35 diseases worldwide. These infections are spread to people through direct communication with rodents, feces, urine, or saliva, or through rodent bites. Infections transmitted by rodents could also be transmitted to people indirectly via ticks, mites, or fleas eaten on an infected rat.

Effective rodent management outside the home is the major technique for preventing human exposure to rodent illnesses. This is accomplished by removing all food sources, closing even the slightest gaps in homes, and successfully capturing rodents in and around the residence. Further, the changing climatic circumstances are significant in the market as global warming changes the population dynamics of rodents and their habitats, as rats breed more prominently in warmer areas.

The global anticoagulant rodenticides market size is expected to reach USD 921.56 million by 2030 according to a new study by Polaris Market Research.

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Climate change is causing a surge in rodent populations, a serious international public health concern. The hantavirus infection is becoming more sensitive to environmental factors. Rodent populations respond more quickly to favorable weather circumstances, such as excessive rainfall, which might directly or indirectly spread rodent-borne infections such as spirosis zoonotic bacterial disease with an undetermined but likely significant human and veterinary frequency.

See also  Anticoagulant Rodenticides Market Will Reach USD 921.56 Million By 2030, at 3.5% CAGR: According to Polaris Market Research

Based on the product, the 1st generation anticoagulants rodenticides market segment accounted for the leading share in the market in 2021. Because of its capacity to break down faster than 2nd generation anticoagulants rodenticides, the first-generation rodenticides product type category accounted for a significant revenue share. The future market expansion of first and second-generation rodenticides, both quantity and income, is strongly related to consumer awareness of good manufacturing practices and government regulations.

Request for Discount on this Report Before Purchase @

Top Market Players

Market players such as NEOGEN Corporation, Bayer AG, Bell Labs., Heranba Industries Ltd., Kalyani Industries Limited, BASF SE, Syngenta Crop Protection AG, PelGar International, Rentokil Initial plc, Liphatech, Inc., and UPL are key players operating in the global anticoagulant rodenticides industry.

In May 2021, BASF introduced Selontra, a novel rodenticide bait that it claims can reduce rodent infections in just seven days. The bait contains cholecalciferol, a novel active mechanism of action to which mice are not known to be resistant. Cholecalciferol has a rapid onset of action and stops mouse feeding within 24 hours. This reduces feed wastage and the biosecurity danger posed by rats in agriculture. Concerns about resistance to anticoagulant rodenticides baits necessitated the development of a new action to combat so-called “super rats” that had limited access to difenacoum and bromadiolone active ingredients, which are used in a variety of conventional baits.

Browse detailed report with in-depth TOC @

Polaris Market Research has segmented the anticoagulant rodenticides market report based on product, form, application, and region:

Anticoagulant Rodenticides, Product Outlook (Revenue – USD Million, 2018 – 2030)

  • 1st Generation Anticoagulants
  • 2nd Generation Anticoagulants
See also  Global Sleeping Aids Market Size Estimated to Reach USD 118.31 Billion by 2030

Anticoagulant Rodenticides, Form Outlook (Revenue – USD Million, 2018 – 2030)

  • Pellets
  • Blocks
  • Powders & Sprays

Anticoagulant Rodenticides, Application Outlook (Revenue – USD Million, 2018 – 2030)

  • Agriculture
  • Pest Control Companies
  • Warehouses
  • Urban Centers
  • Household
  • Others
About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.
Contact Us:
Polaris Market Research
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Ph: +1-929 297-9727